−5.862EUR
−279.48 MEUR
14.35 MEUR
42.55 M
About UNIQURE N.V. EO -,05
Sector
Industry
CEO
Matthew C. Kapusta
Website
Headquarters
Amsterdam
Employees (FY)
480
Founded
2012
ISIN
NL0010696654
FIGI
BBG005ZVQ066
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange UNIQURE N.V. EO -,05 stocks are traded under the ticker UQ1.
UNIQURE N.V. EO -,05 is going to release the next earnings report on Apr 29, 2024. Keep track of upcoming events with our Earnings Calendar.
UQ1 earnings for the last quarter are −1.78 EUR per share, whereas the estimation was −0.81 EUR resulting in a −120.00% surprise. The estimated earnings for the next quarter are −1.32 EUR per share. See more details about UNIQURE N.V. EO -,05 earnings.
UNIQURE N.V. EO -,05 revenue for the last quarter amounts to 1.33 M EUR despite the estimated figure of 27.90 M EUR. In the next quarter revenue is expected to reach 5.07 M EUR.
Yes, you can track UNIQURE N.V. EO -,05 financials in yearly and quarterly reports right on TradingView.
UQ1 net income for the last quarter is −66.33 M EUR, while the quarter before that showed −84.73 M EUR of net income which accounts for 21.72% change. Track more UNIQURE N.V. EO -,05 financial stats to get the full picture.
No, UQ1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, UQ1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UNIQURE N.V. EO -,05 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 480.00 employees. See our rating of the largest employees — is UNIQURE N.V. EO -,05 on this list?
We've gathered analysts' opinions on UNIQURE N.V. EO -,05 future price: according to them, UQ1 price has a max estimate of 27.70 EUR and a min estimate of 6.46 EUR. Read a more detailed UNIQURE N.V. EO -,05 forecast: see what analysts think of UNIQURE N.V. EO -,05 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UNIQURE N.V. EO -,05 EBITDA is −188.52 M EUR, and current EBITDA margin is −1.64 K%. See more stats in UNIQURE N.V. EO -,05 financial statements.